Moderna's stock surged nearly 180% in a single session after the company announced positive Phase 3 trial results for its mRNA-based cancer vaccine therapy.
CafeF08/20, 10:37 AM
Related assets
Coming up for MRNA
Explore next
Latest MRNA news
Jin1010/23, 05:33 AM
Jin1010/23, 03:02 AM
Jin1010/23, 12:41 AM